Strain Name:

B6;129S4-E2f1tm1Meg/J

Stock Number:

002785

Order this mouse

Availability:

Repository- Live

Use Restrictions Apply, see Terms of Use
Mice homozygous for the E2f1 knock-out show thymocyte maturation defects due to a failure of apoptosis, eventually resulting in increased proliferation and increased tumorigenesis. These mice may be useful in studies of apoptosis, cancer, thymocyte development/selection, diabetes, autoimmunity, and multiple sclerosis.

Description

Strain Information

Type Mutant Stock; Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Mating SystemHomozygote x Homozygote         (Female x Male)   01-MAR-06
Specieslaboratory mouse
GenerationF?+19N1F21 (31-DEC-12)
Generation Definitions
 
Donating InvestigatorDr. Michael E. Greenberg,   Harvard Medical School

Appearance
white-bellied agouti
Related Genotype: Aw/Aw

Description
Mice homozygous for defective E2f1 are viable and fertile. They show thymocyte maturation defects due to a failure of apoptosis, eventually resulting in increased proliferation and increased tumorigenesis. As mutant mice age, they show exocrine gland dysplasia and testicular atrophy. Mutant mice develop a broad spectrum of cancers, although mammary carcinomas were not observed on this genetic background. Mutant mice are also protected from experimental autoimmune encephalomyelitis (EAE). These mice may be useful in studies of apoptosis, cancer, thymocyte development/selection, diabetes, autoimmunity, and multiple sclerosis.

Development
This strain was developed by Dr. Seth Field in the laboratory of Dr. Michael Greenberg at Children's Hospital, Boston, MA. The DNA binding domain and part of the dimerization domain of the E2f1 gene were interrupted by a vector containing the neomycin resistance gene.

Control Information

  Control
   101045 B6129SF2/J (approximate)
 
  Considerations for Choosing Controls

Related Strains

Strains carrying other alleles of E2f1
014531   B6;129S2-E2f1tm1Njd/Mmjax
View Strains carrying other alleles of E2f1     (1 strain)

Phenotype

Phenotype Information

View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype

E2f1tm1Meg/E2f1tm1Meg

        involves: 129S4/SvJae * C57BL/6
  • cellular phenotype
  • abnormal cell death
    • cell death induced by Myc expression in primary fibroblast cells is severely impaired   (MGI Ref ID J:75726)
    • however, fibroblast cells retain their capacity to respond to other apoptotic signals   (MGI Ref ID J:75726)
  • immune system phenotype
  • decreased T cell proliferation
    • T cell receptor stimulated proliferation is impaired   (MGI Ref ID J:76318)
  • hematopoietic system phenotype
  • decreased T cell proliferation
    • T cell receptor stimulated proliferation is impaired   (MGI Ref ID J:76318)

The following phenotype information is associated with a similar, but not exact match to this JAX® Mice strain.

E2f1tm1Meg/E2f1tm1Meg

        either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)
  • mortality/aging
  • premature death
    • as null animals age, they die at a significantly higher rate than wild-type littermates   (MGI Ref ID J:33100)
  • growth/size/body phenotype
  • decreased body weight
    • nulls weigh 17% less than wild-type littermates for at least the first 8 weeks of life   (MGI Ref ID J:33100)
  • cellular phenotype
  • decreased apoptosis
    • thymocytes from null mice show increased vialbility in culture with 0% viability over 24 hours compared with 40% viability of wild-type thymocytes   (MGI Ref ID J:33100)
  • immune system phenotype
  • abnormal double-positive T cell morphology
    • double positive cells from null mice display clear enhancement of survival in culture compared to wild-type double-positive cells; in vivo, thymocytes from nulls show significantly less CD3epsilon induced apoptosis compared to wild-type   (MGI Ref ID J:33100)
  • enlarged thymus
    • in 4 to 6 week old null animals, thymi were noticeably enlarged compared to wild-type   (MGI Ref ID J:33100)
    • increased thymus weight
      • the ratio of thymus:body weight is 25% higher in nulls relative to wild-type   (MGI Ref ID J:33100)
  • increased CD4-positive T cell number
    • thymuses of 4-6 week old null mice contain more mature CD4+ cells than wild-type   (MGI Ref ID J:33100)
  • increased CD8-positive T cell number
    • thymuses of 4-6 week old null mice contain more mature CD8+ cells than wild-type   (MGI Ref ID J:33100)
  • increased thymocyte number
    • there is a 55% increase in number of thymocytes per thymus in null mice 4-6 weeks old   (MGI Ref ID J:33100)
  • reproductive system phenotype
  • testicular atrophy
    • in 6-12 month old mice, males show moderate testicular atrophy, characterized by a reduction in testicular weight   (MGI Ref ID J:33100)
  • hematopoietic system phenotype
  • abnormal double-positive T cell morphology
    • double positive cells from null mice display clear enhancement of survival in culture compared to wild-type double-positive cells; in vivo, thymocytes from nulls show significantly less CD3epsilon induced apoptosis compared to wild-type   (MGI Ref ID J:33100)
  • enlarged thymus
    • in 4 to 6 week old null animals, thymi were noticeably enlarged compared to wild-type   (MGI Ref ID J:33100)
    • increased thymus weight
      • the ratio of thymus:body weight is 25% higher in nulls relative to wild-type   (MGI Ref ID J:33100)
  • increased CD4-positive T cell number
    • thymuses of 4-6 week old null mice contain more mature CD4+ cells than wild-type   (MGI Ref ID J:33100)
  • increased CD8-positive T cell number
    • thymuses of 4-6 week old null mice contain more mature CD8+ cells than wild-type   (MGI Ref ID J:33100)
  • increased thymocyte number
    • there is a 55% increase in number of thymocytes per thymus in null mice 4-6 weeks old   (MGI Ref ID J:33100)
  • endocrine/exocrine gland phenotype
  • decreased salivation
    • E2f1 knockouts have reduced salivary flow rates than NOD controls or the standard (NOD x B10.D2) F1 mice   (MGI Ref ID J:93708)
  • testicular atrophy
    • in 6-12 month old mice, males show moderate testicular atrophy, characterized by a reduction in testicular weight   (MGI Ref ID J:33100)
  • tumorigenesis
  • increased T cell derived lymphoma incidence
    • one 6-12 month old animal exhibited a lymphoblastic lymphoma   (MGI Ref ID J:33100)
  • digestive/alimentary phenotype
  • decreased salivation
    • E2f1 knockouts have reduced salivary flow rates than NOD controls or the standard (NOD x B10.D2) F1 mice   (MGI Ref ID J:93708)
  • hearing/vestibular/ear phenotype
  • *normal* hearing/vestibular/ear phenotype
    • at E18.5, homozygotes display a normal morphology of inner ear sensory epithelia relative to wild-type mice   (MGI Ref ID J:98518)

E2f1tm1Meg/E2f1tm1Meg

        involves: 129 * C57BL/6 * FVB/N * NMRI
  • vision/eye phenotype
  • abnormal cone electrophysiology
    • photopic response is slightly reduced relative to normal   (MGI Ref ID J:124204)
  • abnormal retinal bipolar cell morphology
    • mice have slightly fewer bipolar cells at P18 or P30   (MGI Ref ID J:124204)
    • however, the proportion of bipolar cells is normal   (MGI Ref ID J:124204)
  • abnormal retinal progenitor cell morphology
    • retinal progenitor cell proliferation is decreased 2-fold   (MGI Ref ID J:124204)
  • decreased retinal ganglion cell number
    • mice have slightly fewer ganglion cells at P0   (MGI Ref ID J:124204)
  • thin retinal outer nuclear layer
    • the retinal outer nuclear layer is slightly reduced in thickness at P18 or P30   (MGI Ref ID J:124204)
  • nervous system phenotype
  • abnormal retinal bipolar cell morphology
    • mice have slightly fewer bipolar cells at P18 or P30   (MGI Ref ID J:124204)
    • however, the proportion of bipolar cells is normal   (MGI Ref ID J:124204)
  • decreased retinal ganglion cell number
    • mice have slightly fewer ganglion cells at P0   (MGI Ref ID J:124204)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Apoptosis Research

Cancer Research

Diabetes and Obesity Research

Immunology, Inflammation and Autoimmunity Research
Autoimmunity
      experimental allergic encephalomyelitis (EAE)

Internal/Organ Research
Wound Healing
      delayed/impaired

E2f1tm1Meg related

Apoptosis Research
Endogenous Regulators

Cancer Research
Increased Tumor Incidence
      Lymphomas
      Other Tissues/Organs
      Other Tissues/Organs: multiple
Tumor Suppressor Genes

Immunology, Inflammation and Autoimmunity Research
Intracellular Signaling Molecules

Genes & Alleles

Gene & Allele Information provided by MGI

 
Allele Symbol E2f1tm1Meg
Allele Name targeted mutation 1, Michael E Greenburg
Allele Type Targeted (knock-out)
Common Name(s) E2F-1-; E2f1-;
Mutation Made ByDr. Seth Field,   Harvard Medical School
Strain of Origin129S4/SvJae
ES Cell Line NameJ1
ES Cell Line Strain129S4/SvJae
Gene Symbol and Name E2f1, E2F transcription factor 1
Chromosome 2
Gene Common Name(s) E2F-1; RBAP1; RBBP3; RBP3;
Molecular Note Part of exon 3, intron 3 and exon 4 were replaced with a neomycin cassette. These sequences encode residues encoding the leucine zipper and those critical for DNA binding. Northern blot analysis did not detect a transcript made from this allele in fibroblasts isolated from homozygous embryos. [MGI Ref ID J:33100]

Genotyping

Genotyping Information

Genotyping Protocols

E2f1tm1Meg, Standard PCR
E2f1tm1Meg, Melt Curve Analysis


Helpful Links

Genotyping resources and troubleshooting

References

References provided by MGI

Selected Reference(s)

Field SJ; Tsai FY; Kuo F; Zubiaga AM; Kaelin WG Jr; Livingston DM; Orkin SH; Greenberg ME. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85(4):549-61. [PubMed: 8653790]  [MGI Ref ID J:33100]

Additional References

D'Souza SJ; Vespa A; Murkherjee S; Maher A; Pajak A; Dagnino L. 2002. E2F-1 Is Essential for Normal Epidermal Wound Repair. J Biol Chem 277(12):10626-32. [PubMed: 11790795]  [MGI Ref ID J:75467]

Gao X; Tewari K; Svaren J; Suresh M. 2004. Role of cell cycle regulator E2F1 in regulating CD8 T cell responses during acute and chronic viral infection. Virology 324(2):567-76. [PubMed: 15207641]  [MGI Ref ID J:102273]

Hou ST; Callaghan D; Fournier MC; Hill I; Kang L; Massie B; Morley P; Murray C; Rasquinha I; Slack R; MacManus JP. 2000. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 75(1):91-100. [PubMed: 10854251]  [MGI Ref ID J:62798]

Hou ST; Xie X; Baggley A; Park DS; Chen G; Walker T. 2002. Activation of the Rb/E2F1 Pathway by the Nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated Neuronal Apoptosis. J Biol Chem 277(50):48764-70. [PubMed: 12351630]  [MGI Ref ID J:80700]

Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM. 2004. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest 113(10):1398-407. [PubMed: 15146237]  [MGI Ref ID J:91105]

Iglesias AH; Camelo S; Hwang D; Villanueva R; Stephanopoulos G; Dangond F. 2004. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells. J Neuroimmunol 150(1-2):163-77. [PubMed: 15081262]  [MGI Ref ID J:110246]

Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR. 2001. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 8(1):105-13. [PubMed: 11511364]  [MGI Ref ID J:75726]

Li FX; Zhu JW; Tessem JS; Beilke J; Varella-Garcia M; Jensen J; Hogan CJ; DeGregori J. 2003. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci U S A 100(22):12935-40. [PubMed: 14566047]  [MGI Ref ID J:86404]

Matsumoto N; Salam MA; Watanabe H; Amagasa T; Senpuku H. 2004. Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice. Oral Microbiol Immunol 19(4):270-6. [PubMed: 15209999]  [MGI Ref ID J:110247]

Smith RA; Walker T; Xie X; Hou ST. 2003. Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Brain Res Mol Brain Res 116(1-2):70-9. [PubMed: 12941462]  [MGI Ref ID J:85607]

Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414(6862):457-62. [PubMed: 11719808]  [MGI Ref ID J:73374]

Zhu JW; Field SJ; Gore L; Thompson M; Yang H; Fujiwara Y; Cardiff RD; Greenberg M; Orkin SH; DeGregori J. 2001. E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis. Mol Cell Biol 21(24):8547-64. [PubMed: 11713289]  [MGI Ref ID J:72952]

E2f1tm1Meg related

Andrechek ER; Mori S; Rempel RE; Chang JT; Nevins JR. 2008. Patterns of cell signaling pathway activation that characterize mammary development. Development 135(14):2403-13. [PubMed: 18550711]  [MGI Ref ID J:137644]

Annicotte JS; Blanchet E; Chavey C; Iankova I; Costes S; Assou S; Teyssier J; Dalle S; Sardet C; Fajas L. 2009. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat Cell Biol 11(8):1017-23. [PubMed: 19597485]  [MGI Ref ID J:158138]

Bhatia B; Hsieh M; Kenney AM; Nahle Z. 2011. Mitogenic Sonic hedgehog signaling drives E2F1-dependent lipogenesis in progenitor cells and medulloblastoma. Oncogene 30(4):410-22. [PubMed: 20890301]  [MGI Ref ID J:168813]

Bilousova G; Marusyk A; Porter CC; Cardiff RD; DeGregori J. 2005. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol 3(12):e401. [PubMed: 16277552]  [MGI Ref ID J:103814]

Blanchet E; Annicotte JS; Lagarrigue S; Aguilar V; Clape C; Chavey C; Fritz V; Casas F; Apparailly F; Auwerx J; Fajas L. 2011. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 13(9):1146-52. [PubMed: 21841792]  [MGI Ref ID J:176966]

Blanchet E; Annicotte JS; Pradelli LA; Hugon G; Matecki S; Mornet D; Rivier F; Fajas L. 2012. E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism. Hum Mol Genet 21(17):3910-7. [PubMed: 22678059]  [MGI Ref ID J:185978]

Cao Q; Xia Y; Azadniv M; Crispe IN. 2004. The E2F-1 transcription factor promotes caspase-8 and bid expression, and enhances Fas signaling in T cells. J Immunol 173(2):1111-7. [PubMed: 15240700]  [MGI Ref ID J:91930]

Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R. 2007. Rb-Mediated Neuronal Differentiation through Cell-Cycle-Independent Regulation of E2f3a. PLoS Biol 5(7):e179. [PubMed: 17608565]  [MGI Ref ID J:124204]

Chen Q; Khoury M; Chen J. 2009. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A :. [PubMed: 19966223]  [MGI Ref ID J:155817]

Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G. 2009. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol 29(2):414-24. [PubMed: 19015245]  [MGI Ref ID J:144747]

Chong JL; Wenzel PL; Saenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G. 2009. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462(7275):930-4. [PubMed: 20016602]  [MGI Ref ID J:155799]

Cooper-Kuhn CM; Vroemen M; Brown J; Ye H; Thompson MA; Winkler J; Kuhn HG. 2002. Impaired adult neurogenesis in mice lacking the transcription factor E2F1. Mol Cell Neurosci 21(2):312-23. [PubMed: 12401450]  [MGI Ref ID J:80102]

Costa C; Santos M; Martinez-Fernandez M; Duenas M; Lorz C; Garcia-Escudero R; Paramio JM. 2013. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis. Oncogene 32(24):2937-51. [PubMed: 22890321]  [MGI Ref ID J:198014]

DeRyckere D; DeGregori J. 2005. E2F1 and E2F2 are differentially required for homeostasis-driven and antigen-induced T cell proliferation in vivo. J Immunol 175(2):647-55. [PubMed: 16002659]  [MGI Ref ID J:101673]

Donovan SL; Corbo JC. 2012. Retinal horizontal cells lacking Rb1 sustain persistent DNA damage and survive as polyploid giant cells. Mol Biol Cell 23(22):4362-72. [PubMed: 23015754]  [MGI Ref ID J:200265]

Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A. 2006. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9(6):459-71. [PubMed: 16766265]  [MGI Ref ID J:110132]

Fujiwara K; Yuwanita I; Hollern DP; Andrechek ER. 2011. Prediction and Genetic Demonstration of a Role for Activator E2Fs in Myc-Induced Tumors. Cancer Res 71(5):1924-32. [PubMed: 21245101]  [MGI Ref ID J:169307]

Garcia I; Murga M; Vicario A; Field SJ; Zubiaga AM. 2000. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ 11(2):91-8. [PubMed: 10714765]  [MGI Ref ID J:133835]

Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR. 1998. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1 Oncogene 16(19):2489-501. [PubMed: 9627115]  [MGI Ref ID J:47889]

Hoglinger GU; Breunig JJ; Depboylu C; Rouaux C; Michel PP; Alvarez-Fischer D; Boutillier AL; Degregori J; Oertel WH; Rakic P; Hirsch EC; Hunot S. 2007. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A 104(9):3585-90. [PubMed: 17360686]  [MGI Ref ID J:126079]

Hou ST; Callaghan D; Fournier MC; Hill I; Kang L; Massie B; Morley P; Murray C; Rasquinha I; Slack R; MacManus JP. 2000. The transcription factor E2F1 modulates apoptosis of neurons. J Neurochem 75(1):91-100. [PubMed: 10854251]  [MGI Ref ID J:62798]

Hsieh MC; Das D; Sambandam N; Zhang MQ; Nahle Z. 2008. Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem 283(41):27410-7. [PubMed: 18667418]  [MGI Ref ID J:142320]

Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM. 2004. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest 113(10):1398-407. [PubMed: 15146237]  [MGI Ref ID J:91105]

Iglesias-Ara A; Zenarruzabeitia O; Fernandez-Rueda J; Sanchez-Tillo E; Field SJ; Celada A; Zubiaga AM. 2010. Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21(CIP1)-dependent senescence. Oncogene 29(41):5579-90. [PubMed: 20676136]  [MGI Ref ID J:165294]

Ishii H; Mimori K; Yoshikawa Y; Mori M; Furukawa Y; Vecchione A. 2005. Differential Roles of E-Type Cyclins During Transformation of Murine E2F-1-Deficient Cells. DNA Cell Biol 24(3):173-9. [PubMed: 15767783]  [MGI Ref ID J:97842]

Ishimaru N; Arakaki R; Omotehara F; Yamada K; Mishima K; Saito I; Hayashi Y. 2006. Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 26(8):2924-35. [PubMed: 16581768]  [MGI Ref ID J:107385]

Jiang SX; Sheldrick M; Desbois A; Slinn J; Hou ST. 2007. Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo. Mol Cell Biol 27(5):1696-705. [PubMed: 17178835]  [MGI Ref ID J:118900]

Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E. 2000. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis Dev Biol 227(1):28-41. [PubMed: 11076674]  [MGI Ref ID J:65679]

Kim TH; Goodman J; Anderson KV; Niswander L. 2007. Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression. Dev Cell 13(1):87-102. [PubMed: 17609112]  [MGI Ref ID J:123924]

Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR. 2001. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 8(1):105-13. [PubMed: 11511364]  [MGI Ref ID J:75726]

Li FX; Zhu JW; Hogan CJ; DeGregori J. 2003. Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice. Mol Cell Biol 23(10):3607-22. [PubMed: 12724419]  [MGI Ref ID J:83284]

Li FX; Zhu JW; Tessem JS; Beilke J; Varella-Garcia M; Jensen J; Hogan CJ; DeGregori J. 2003. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci U S A 100(22):12935-40. [PubMed: 14566047]  [MGI Ref ID J:86404]

Liu Y; Zacksenhaus E. 2000. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Oncogene 19(52):6065-73. [PubMed: 11146559]  [MGI Ref ID J:66392]

MacManus JP; Koch CJ; Jian M; Walker T; Zurakowski B. 1999. Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1. Neuroreport 10(13):2711-4. [PubMed: 10511428]  [MGI Ref ID J:59752]

Mantela J; Jiang Z; Ylikoski J; Fritzsch B; Zacksenhaus E; Pirvola U. 2005. The retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear. Development 132(10):2377-88. [PubMed: 15843406]  [MGI Ref ID J:98518]

McClellan KA; Ruzhynsky VA; Douda DN; Vanderluit JL; Ferguson KL; Chen D; Bremner R; Park DS; Leone G; Slack RS. 2007. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions. Mol Cell Biol 27(13):4825-43. [PubMed: 17452454]  [MGI Ref ID J:122733]

Murga M; Fernandez-Capetillo O; Field SJ; Moreno B; Borlado LR; Fujiwara Y; Balomenos D; Vicario A; Carrera AC; Orkin SH; Greenberg ME; Zubiaga AM. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15(6):959-70. [PubMed: 11754817]  [MGI Ref ID J:76318]

Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O. 2007. Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J 26(4):987-97. [PubMed: 17290223]  [MGI Ref ID J:120099]

Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G. 2007. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci U S A 104(39):15400-5. [PubMed: 17881568]  [MGI Ref ID J:125304]

Palmero I; Murga M; Zubiaga A; Serrano M. 2002. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene 21(19):2939-47. [PubMed: 12082524]  [MGI Ref ID J:126187]

Pandit SK; Westendorp B; Nantasanti S; van Liere E; Tooten PC; Cornelissen PW; Toussaint MJ; Lamers WH; de Bruin A. 2012. E2F8 is essential for polyploidization in mammalian cells. Nat Cell Biol 14(11):1181-91. [PubMed: 23064264]  [MGI Ref ID J:190714]

Qin G; Kishore R; Dolan CM; Silver M; Wecker A; Luedemann CN; Thorne T; Hanley A; Curry C; Heyd L; Dinesh D; Kearney M; Martelli F; Murayama T; Goukassian DA; Zhu Y; Losordo DW. 2006. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A 103(29):11015-20. [PubMed: 16835303]  [MGI Ref ID J:111802]

Raimundo N; Song L; Shutt TE; McKay SE; Cotney J; Guan MX; Gilliland TC; Hohuan D; Santos-Sacchi J; Shadel GS. 2012. Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness. Cell 148(4):716-26. [PubMed: 22341444]  [MGI Ref ID J:181548]

Redmond WL; Wei CH; Kreuwel HT; Sherman LA. 2008. The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigen. J Immunol 180(8):5275-82. [PubMed: 18390708]  [MGI Ref ID J:134242]

Rempel RE; Mori S; Gasparetto M; Glozak MA; Andrechek ER; Adler SB; Laakso NM; Lagoo AS; Storms R; Smith C; Nevins JR. 2009. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. PLoS Genet 5(9):e1000640. [PubMed: 19749980]  [MGI Ref ID J:154120]

Saenz Robles MT; Case A; Chong JL; Leone G; Pipas JM. 2011. The retinoblastoma tumor suppressor regulates a xenobiotic detoxification pathway. PLoS One 6(10):e26019. [PubMed: 22022495]  [MGI Ref ID J:178100]

Saenz-Robles MT; Markovics JA; Chong JL; Opavsky R; Whitehead RH; Leone G; Pipas JM. 2007. Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2. J Virol 81(23):13191-9. [PubMed: 17855529]  [MGI Ref ID J:129937]

Salam MA; Matin K; Matsumoto N; Tsuha Y; Hanada N; Senpuku H. 2004. E2f1 mutation induces early onset of diabetes and Sjogren's syndrome in nonobese diabetic mice. J Immunol 173(8):4908-18. [PubMed: 15470032]  [MGI Ref ID J:93708]

Sharma N; Timmers C; Trikha P; Saavedra HI; Obery A; Leone G. 2006. Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J Biol Chem 281(47):36124-31. [PubMed: 17008321]  [MGI Ref ID J:117634]

Sung YH; Kim HJ; Devkota S; Roh J; Lee J; Rhee K; Bahk YY; Lee HW. 2010. Pierce1, a novel p53 target gene contributing to the ultraviolet-induced DNA damage response. Cancer Res 70(24):10454-63. [PubMed: 21159655]  [MGI Ref ID J:167598]

Tessem JS; Jensen JN; Pelli H; Dai XM; Zong XH; Stanley ER; Jensen J; DeGregori J. 2008. Critical roles for macrophages in islet angiogenesis and maintenance during pancreatic degeneration. Diabetes 57(6):1605-17. [PubMed: 18375440]  [MGI Ref ID J:136898]

Trikha P; Sharma N; Opavsky R; Reyes A; Pena C; Ostrowski MC; Roussel MF; Leone G. 2011. E2f1-3 are critical for myeloid development. J Biol Chem 286(6):4783-95. [PubMed: 21115501]  [MGI Ref ID J:169491]

Tsai SY; Opavsky R; Sharma N; Wu L; Naidu S; Nolan E; Feria-Arias E; Timmers C; Opavska J; de Bruin A; Chong JL; Trikha P; Fernandez SA; Stromberg P; Rosol TJ; Leone G. 2008. Mouse development with a single E2F activator. Nature 454(7208):1137-41. [PubMed: 18594513]  [MGI Ref ID J:138289]

Tsume M; Kimura-Yoshida C; Mochida K; Shibukawa Y; Amazaki S; Wada Y; Hiramatsu R; Shimokawa K; Matsuo I. 2012. Brd2 is required for cell cycle exit and neuronal differentiation through the E2F1 pathway in mouse neuroepithelial cells. Biochem Biophys Res Commun 425(4):762-8. [PubMed: 22885183]  [MGI Ref ID J:188139]

Wang ZM; Yang H; Livingston DM. 1998. Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. Proc Natl Acad Sci U S A 95(26):15583-6. [PubMed: 9861012]  [MGI Ref ID J:119885]

Warg LA; Oakes JL; Burton R; Neidermyer AJ; Rutledge HR; Groshong S; Schwartz DA; Yang IV. 2012. The role of the E2F1 transcription factor in the innate immune response to systemic LPS. Am J Physiol Lung Cell Mol Physiol 303(5):L391-400. [PubMed: 22707615]  [MGI Ref ID J:191903]

Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE. 2003. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol 5(7):655-60. [PubMed: 12833065]  [MGI Ref ID J:84051]

Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414(6862):457-62. [PubMed: 11719808]  [MGI Ref ID J:73374]

Yan Z; Choi S; Liu X; Zhang M; Schageman JJ; Lee SY; Hart R; Lin L; Thurmond FA; Williams RS. 2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278(10):8826-36. [PubMed: 12477723]  [MGI Ref ID J:82190]

Zencak D; Schouwey K; Chen D; Ekstrom P; Tanger E; Bremner R; van Lohuizen M; Arsenijevic Y. 2013. Retinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins. Proc Natl Acad Sci U S A 110(7):E593-601. [PubMed: 23359713]  [MGI Ref ID J:194322]

Zhang J; Bahi N; Zubiaga AM; Comella JX; Llovera M; Sanchis D. 2007. Developmental silencing and independency from E2F of apoptotic gene expression in postmitotic tissues. FEBS Lett 581(30):5781-6. [PubMed: 18037375]  [MGI Ref ID J:129205]

Zhang J; Cicero SA; Wang L; Romito-Digiacomo RR; Yang Y; Herrup K. 2008. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci U S A 105(25):8772-7. [PubMed: 18550843]  [MGI Ref ID J:137191]

Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J. 1999. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ 10(12):829-38. [PubMed: 10616908]  [MGI Ref ID J:133836]

Zhu JW; Field SJ; Gore L; Thompson M; Yang H; Fujiwara Y; Cardiff RD; Greenberg M; Orkin SH; DeGregori J. 2001. E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis. Mol Cell Biol 21(24):8547-64. [PubMed: 11713289]  [MGI Ref ID J:72952]

Health & husbandry

Health & Colony Maintenance Information

Animal Health Reports

Room Number           FGB27

Colony Maintenance

Breeding & HusbandryThis strain is currently on a mixed C57BL/6 x 129 genetic backgrounds. Litter sizes are reported to be 5-6 pups for these mixed background mice. Homozygotes viable and fertile. Expected coat color from breeding:White Bellied Agouti
Mating SystemHomozygote x Homozygote         (Female x Male)   01-MAR-06
Diet Information LabDiet® 5K52/5K67

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls


Pricing for USA, Canada and Mexico shipping destinations View International Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $195.00Female or MaleHomozygous for E2f1tm1Meg  
Price per Pair (US dollars $)Pair Genotype
$390.00Homozygous for E2f1tm1Meg x Homozygous for E2f1tm1Meg  

Standard Supply

Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.

Pricing for International shipping destinations View USA Canada and Mexico Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $253.50Female or MaleHomozygous for E2f1tm1Meg  
Price per Pair (US dollars $)Pair Genotype
$507.00Homozygous for E2f1tm1Meg x Homozygous for E2f1tm1Meg  

Standard Supply

Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.

Control Information

  Control
   101045 B6129SF2/J (approximate)
 
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.
 

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.


See Terms of Use tab for General Terms and Conditions


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


For Licensing and Use Restrictions view the link(s) below:
- Notice to customers in Canada.

Contact information

General inquiries regarding Terms of Use

Contracts Administration

phone:207-288-6470

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.


(6.6)